Barrett & Company’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
Barrett & Company's CME Position: Q3 2026 in Review
Barrett & Company reduced its CME Group (CME) stake by 74% in Q3 2026, selling an estimated $173K and leaving 225 shares worth $58.9K. The position accounts for 0.02% of the portfolio, ranked #286.
Barrett & Company first reported a position in CME in Q3 2022 and has held it in 17 quarters since. The position peaked at $195K in Q2 2026. 1,080 funds tracked by Wall St. Rank hold CME as of Q3 2026.
- Barrett & Company held 225 shares of CME Group worth $58.9K as of Q3 2026.
- Barrett & Company sold 657 CME Group shares in Q3 2026, an estimated $173K.
- CME Group made up 0.02% of Barrett & Company's portfolio in Q3 2026, its #286 holding.
- Barrett & Company first reported a position in CME Group in Q3 2022 and has held it in 17 quarters since.
- Barrett & Company's CME Group position peaked at $195K in Q2 2026.
- 1,080 funds tracked by Wall St. Rank held CME Group as of Q3 2026.
Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.